Rodan seems to have good credentials and experience in biotechnology. Unfortunately, I believe he's categorically incorrect in this thesis. OCA's side effects are real, not imaginary. And, there are numerous, better funded entities, chasing NASH. A $465 price target? In his dreams.
2016 will be more of the Same growth trajectory -- Japan now in the fold. Harvoni soaring. Oncology pipeline. Excellent Pipeline, Plenty of Cash for acquisitions, if beneficial. Great buyback in process and a decent dividend. 2016 will be a very good year, imo.
Intercept is a GIANT con as a solution to NASH -- trying to hide the truth about the dangerous side effects won't work. Too many people will die from the incredible increases in Bad cholesterol along w/ the decrease in Good cholesterol. March 24-28 --- Insider dumped $100,000,000. of his shares b/c he sees the writing on the Wall.
Watch and see: This POS will drop like a rock. Serious side effects are no joke. And, this company doesn't create the impression of being totally honest. FLINT study STOPPED by the District court. Insider dumps $100m worth of stock through an LLC in 4 days!!!
Take this: Intercept's Summary Judgment Motion DENIED -- Class Action lawsuit(s) proceed -- Insider dumped $100m of stock in March - over a 4 day period. Wear your helmet, the momentum will crash big time.
the Side effects will hamper or ruin any euphoria. It takes 6-8 months after the drug is distributed to the masses. Shooting Cholesterol levels through the roof will kill distribution and precipitate an endless stream of lawsuits. Breakthrough designation isn't a 'get out of jail free' card -- the side effects will be the Key.
Fundamentals are confirming the Technicals. Earnings at the end of this QTR should be incredibly good. Japan is on board. Harvoni/Sovaldi are just beginning their sustained revenues.
Unfortunately, you can't LIE online anymore -- there are too many ways to check out the dangerous side effects of OCA.
Unfortunately, OCA raised "significant liver abnormalities" -- makes Bad Cholesterol HIGHER and Good Cholesterol LOWER. Dangerous Side effects. Not what the LONGS want to hear but it's the truth.
I don't know where you're getting your information, but it's categorically incorrect. In fact, there was a FINDING of 'significant lipid abnormalities' (increased total cholesterol, increased LDL cholesterol and decreased HDL cholesterol) and U.S. district court judge: "all patient(s) who remain on treatment (OBCA or Placebo) will be discontinued within two weeks of today." Those are the FACTS (not the usual BS from cheerleaders on this Thread).
Wrong again. I've owned GILD for 2 years (almost to the day). Cost me $51/sh -- now, $114. Cramer was no where on Board w/ GILD -- Cramer was pumping Regeneron and CRM night and day. He wasn't positive on GILD - I know, I asked him!
Wrong! Cramer missed GILD by a country mile. He got on Board when viewers texted him. You must be one of the suckers that believe that pump and dump artist.
Hope not. CRM is way over-priced. I can't see the benefit to MSFT but Nadella is a smart guy - perhaps he sees value. If MSFT pulls the trigger, I hope they get CRM at a bargain price.
With all his Bluster, it took Cramer 18 months to figure out that GILD is selling dirt cheap. Of course, w/ Cramer, he'll claim he knew it all along. First class Pumper and toxic to the small investor.
Vinnie: You're a textbook example of a person talking when you should be listening. Go get educated about Biotech and GILD. You're embarrassing yourself.